This is a Validated Antibody Database (VAD) review about mouse Taf4, based on 7 published articles (read how Labome selects the articles), using Taf4 antibody in all methods. It is aimed to help Labome visitors find the most suited Taf4 antibody. Please note the number of articles fluctuates since newly identified citations are added and citations for discontinued catalog numbers are removed regularly.
Taf4 synonym: 135kDa; AI450312; TAFII130; TAFII135; Taf2c1; Taf4a; transcription initiation factor TFIID subunit 4; TAF4A RNA polymerase II, TATA box binding protein (TBP)-associated factor; TATA box binding protein (TBP)-associated factor, RNA polymerase II, C1, 130kd
Santa Cruz Biotechnology
mouse monoclonal (22) |
| Santa Cruz Biotechnology Taf4 antibody (Santa Cruz, sc136093) was used in western blot on human samples at 1:1000 (fig 5). Cell Res (2016) ncbi |
BD Biosciences
mouse monoclonal (22/TAF[II]135) |
| BD Biosciences Taf4 antibody (BD Biosciences, 612054) was used in western blot on human samples (fig 4). Sci Rep (2016) ncbi |
mouse monoclonal (22/TAF[II]135) |
| BD Biosciences Taf4 antibody (BD Biosciences, 612054) was used in dot blot on human samples (fig 1b). elife (2015) ncbi |
mouse monoclonal (22/TAF[II]135) |
| BD Biosciences Taf4 antibody (BD, 612054) was used in western blot on mouse samples (fig 1d). elife (2014) ncbi |
mouse monoclonal (22/TAF[II]135) |
| BD Biosciences Taf4 antibody (BD, 612054) was used in western blot on mouse samples (fig 3). elife (2014) ncbi |
mouse monoclonal (22/TAF[II]135) |
| BD Biosciences Taf4 antibody (BD Transduction Laboratories, 612054) was used in western blot on mouse samples at 1:250. Front Oncol (2014) ncbi |
mouse monoclonal (22/TAF[II]135) |
| BD Biosciences Taf4 antibody (BD Biosciences, 612054) was used in western blot on human samples (fig 1). PLoS ONE (2013) ncbi |
Articles Reviewed
contribute
- If you are aware of any publication with knockout studies validating a monoclonal or recombinant antibody, either purchased from a supplier or developed by the author(s), please notify us through feedback.
questions and comments